Global Osteoporosis Drugs Market; Drivers and Restraints in the Healthcare Insustry, MRFR Unleashes the Forecast by 2022

Market Research Future adds the “Global Osteoporosis Drugs Market Research Report - Forecast to 2022” report to their unique and vast collection.

Pune, India - June 12, 2019 /MarketersMedia/ —

Osteoporosis is a disorder that causes a lower bone mass that results in weakening and micro-architectural deterioration of bone tissues.  Osteoporosis makes bones so brittle that a minor injury or even mild stresses like bending over or coughing can cause a fracture. Osteoporosis drugs are useful in the treatment of low bone density, slowing down bone resorption. These medications reduce the likelihood of having fragility fractures.

The global osteoporosis drugs market is well-established, and there are various effective medicines available to treat the disorder which is invariably driving the growth of the market. Moreover, a growing number of drug manufacturers are escalating the market on the global platform, bringing novel medications in the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2479

Recognizing the colossal traction and gauging the potential of the market to grow in forthcoming years; Market Research Future (MRFR), in its newly published study analysis asserts that the global osteoporosis drugs market will reach a valuation of USD 14,300 MN by 2022, growing at7.2% CAGR over the review period (2017 – 2022).

Additional factors helping the market to grow further include the rise in the geriatric population, gene mutations, changing lifestyle, and addictions such as alcoholism and smoking. Also, drug-induced osteoporosis and rising prevalence of diseases and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, and hormonal disorders, are some of the key factors propelling the growth of the market.

Conversely, factors such as the patent expiries of blockbuster medicines, side effects of these drugs, and the availability of generics are impeding the growth of the market. Also, in some cases, osteoporosis shows very low or poor symptoms which obstructs the market growth.

Nevertheless, factors such as substantial technological strides that have made the osteoporosis drugs more effective, increasing the demand for the treatment measures for osteoporosis are expected to fuel the growth of the market. 

Besides, substantial investments transpired into R&D activities, and improving economic conditions would provide impetus to the growth of the market, increasing the healthcare expenditures and access to excellent health care.

Global Osteoporosis Drugs Market – Segments

For ease of understanding, the analysis has been segmented into four key dynamics: -

By Drug Class                                  : Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), and Parathyroid Hormone (PTH) among others.

By Route Of Administration     : Oral and Injectable among others.

By Gender                                       : Male and Female

By Regions                                      : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Osteoporosis Drugs Market – Regional Analysis

The North American region, heading with the increasing prevalence of osteoporosis is estimated to retain its dominance over the global osteoporosis drugs market. Additional factors such as the presence of a well-developed healthcare sector, high per capita healthcare expenditures, and well-spread awareness drives the regional market.

Furthermore, growing markets in the U.S. and Canada backed by the presence of prominent market players impacts the growth of the regional market, positively.  The region is expected to create a significant revenue pocket registering a robust CAGR throughout the forecast period (2017-2022).

The osteoporosis market in the European region accounts for the second-largest market, globally. Factors such as favorable government support and initiatives and the proliferating healthcare sector backed by the resurging economy are radiantly fostering the growth of the market in the region.

The U.K., backed by its sizeable osteoporosis drugs market and Germany with its vast medical technology and pharmaceutical industry, significantly contributes to the growth of the regional market, is expected to drive the market growth in the region. 

The Asia Pacific osteoporosis drugs market is rapidly emerging as a promising market, globally. Factors such as the spreading awareness towards the disorder and women healthcare alongside the availability of many novel drugs influence the growth of the market, positively.

Moreover, the rising prevalence of osteoporosis in women after menopause, gene mutations, changing lifestyle, and the burgeoning pharmaceutical industry support the growth of the regional market. Furthermore, continually rising healthcare expenditures and favorable government policies, especially in the developing countries like China and India substantiate the market growth in the APAC region.

Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/osteoporosis-drugs-market-2479

Global Osteoporosis Drugs Market – Competitive Analysis

Fiercely competitive, the osteoporosis drugs market appears fragmented with many large and small players churning the competition. Through the strategic initiatives such as partnership, expansion, acquisition, collaboration, and product & technology launch these players try to gain an edge over their competitors.

Major Players:

Key players leading the global osteoporosis drugs market include Merck & Co., Eli Lilly and Company, Novartis International AG, F. Hoffmann La Roche Ltd., Amgen Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Novo Nordisk among others.

Industry, Innovation & Related News

April 16, 2019 –--- Two leading global biopharmaceutical companies UCB (Belgium) and Amgen Inc. (the US) announced the receiving of the US FDA approval for the osteoporosis drug – Evenity that they have developed, collaboratively. This drug is approved to treat osteoporosis in postmenopausal women at high risk of bone fracture. Evenity represents the first new treatment approach after nearly two decades, restoring bone without breaking it down. Based on a rare gene mutation in people with bones so dense that they never break, Evenity, can increase bone formation and decrease bone loss.

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/2479

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/osteoporosis-drugs-market-2479

Source URL: https://marketersmedia.com/global-osteoporosis-drugs-market-drivers-and-restraints-in-the-healthcare-insustry-mrfr-unleashes-the-forecast-by-2022/523312

Source: MarketersMedia

Release ID: 523312

Latest News

How do you teach kids about texting? Bring in the teenagers

Jun 18, 2019

ESSEN, Germany — How do you teach tech-savvy kids to safely navigate the digital world? In Germany, you bring in the teenagers. On a recent day, 18-year-old Chantal Hueben stood in front of a group of fifth-graders and asked them to brainstorm about the messaging program Whatsapp, which most are using to participate in a group chat for their class. They spoke about themes like cyberbullying and what material is OK to post. "Many are not really aware yet of the impact their messages can have on others," says Hueben, dressed all in black except for white sneakers. "We're teaching...

Apple previews new software as it diversifies beyond iPhones

Jun 18, 2019

SAN JOSE, Calif. — Apple, beset by falling iPhone sales, announced upcoming changes to its phone and computer software intended to highlight its new digital services and to further position it as a defender of personal privacy. The revisions previewed Monday during a conference in San Jose, California, included a new feature that will let people log into apps and other services with an Apple ID instead of relying on similar sign-in options from Facebook and Google — two companies that mine data to sell advertising. Apple said it won't collect tracking information about users from that service. As part...

Virtual reality helps police learn to interact with autistic

Jun 18, 2019

WASHINGTON — An autistic man walks out of a store without paying for a toy he picked up. He's followed by a storekeeper demanding he come back inside. The situation quickly escalates, and police are called. Officers arrive, their patrol car's lights flashing and sirens blaring, to find the man in the parking lot, yelling and not responding to their commands. They have a choice: confront the man and risk having the situation turn violent or regroup to figure out a different approach. The scenario is part of a virtual reality simulation for police that's being developed by Axon —...

Anti-groping smartphone app highly popular in Japan

Jun 18, 2019

TOKYO — A smartphone app developed by Japanese police is being widely downloaded by women trying to protect themselves from gropers on packed rush-hour trains. The "Digi Police" app was originally issued by Tokyo police three years ago, but a function to scare off molesters was only added a few months ago. Since then, the app has reportedly been downloaded hundreds of thousands of times — unusual for a government-developed mobile application. Women in crowded trains and other public places in Japan often face sexual harassment, but are typically too afraid to call out for help. With the app, victims...

Nonprofits turn to cryptocurrency to help needy Venezuelans

Jun 18, 2019

BARQUISIMETO, Venezuela — Andreina Cordero started the year skipping meals so her three kids could eat. Her husband, a construction worker, was out of a job. And the family's savings had been devastated by the nation's hyperinflation, limiting Cordero's children to a diet of rice, beans, pasta and fried corn patties. But the family got a break from their daily struggle to feed themselves this spring when a social worker enrolled them in a program run by a Silicon Valley startup that is donating cryptocurrency to hundreds of Venezuelan families. Every week from February to April, Cordero received a deposit...

About Us

Science Thread delivers quality and fascinating science and technology content that matters on a daily basis and makes it go viral.

Contact us: sales@sciencethread.com